Extended Data Fig. 2: Association between the expression levels of Pglyrp1 and survival rate in different human cancers. | Nature Immunology

Extended Data Fig. 2: Association between the expression levels of Pglyrp1 and survival rate in different human cancers.

From: Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation

Extended Data Fig. 2: Association between the expression levels of Pglyrp1 and survival rate in different human cancers.

Overall survival of patients with breast cancer (BRCA) (n = 1,100), HER2-positive BRCA (BRCA-Her2) (n = 82), colon adenocarcinoma (COAD) (n = 458), and lung squamous cell carcinoma (LUSC) (n = 501) grouped by PGLRYP1 expression through TIMER2 database70. Split expression percentage of patients: 20%. Analyses were performed with log-rank Mantel-Cox test. Hazard ratio (HR) and p-value are provided.

Back to article page